Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q2 FY24 results · Jul–Sep 2023
Bajaj Healthcare reported revenue from operations of ₹101.21 crore (down 49.6% from Q2 FY23) and net loss of ₹3.46 crore for Q2 FY24 (Jul–Sep 2023), on a standalone basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 101.21 | 200.89 | −49.6% | 129.74 | −22.0% |
| Other income | 1.22 | 0.13 | +824.8% | 0.22 | +458.0% |
| Total income | 102.43 | 201.03 | −49.0% | 129.95 | −21.2% |
| Profit before tax | 5.24 | 22.02 | −76.2% | 6.90 | −24.1% |
| Net profit for the period | (3.46) | 16.36 | Turned loss | (48.21) | Loss narrowed |
| EPS, basic (₹) | (1.25) | 5.93 | Turned loss | (17.46) | Loss narrowed |
| Net margin (%) | -3.4 | 8.1 | -37.2 |
Standalone
- Filed with BSE
- 23 Nov 2023, 10:58 IST
- Board meeting
- 09 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE